- Training
- June 2021
- 2 Days
Global
From €1653EUR$1,699USD£1,416GBP
- Training
- August 2020
- 2 Days
Global
From €1848EUR$1,899USD£1,583GBP
- Webinar
- September 2019
- 120 Minutes
Global
- Webinar
- August 2019
- 180 Minutes
Global
- Webinar
- July 2019
- 60 Minutes
Global
- Webinar
- May 2019
- 60 Minutes
Global
- Webinar
- March 2019
- 60 Minutes
Global
- Webinar
- February 2019
- 90 Minutes
Europe
- Webinar
- February 2019
- 90 Minutes
Global
- Webinar
- December 2018
- 120 Minutes
Global
- Webinar
- November 2018
- 180 Minutes
Global
From €290EUR$298USD£248GBP
- Webinar
- October 2018
- 90 Minutes
Global
- Webinar
- September 2018
- 90 Minutes
Global
- Webinar
- June 2018
- 90 Minutes
Global
- Training
- 12 Hours
Global
€4378EUR$4,500USD£3,751GBP
From €1945EUR$1,999USD£1,666GBP
From €1069EUR$1,099USD£916GBP
- Webinar
- August 2022
- 360 Minutes
Global
From €579EUR$595USD£496GBP
- Webinar
- May 2023
- 90 Minutes
Global
From €185EUR$190USD£158GBP
- Webinar
- May 2022
- 240 Minutes
Global
From €482EUR$495USD£413GBP
The FDA Warning Letter market within the context of Pharmaceutical Manufacturing is a market that focuses on the enforcement of regulations and standards set by the U.S. Food and Drug Administration (FDA). Companies in this market are responsible for ensuring that their products meet the FDA's requirements for safety, efficacy, and quality. Companies must also comply with the FDA's Good Manufacturing Practices (GMPs) and other regulations. Companies that fail to meet these standards may receive a warning letter from the FDA, which can result in fines, product recalls, or other penalties. Companies in this market must also be aware of the latest developments in the industry, such as new regulations or changes to existing regulations.
Some companies in the FDA Warning Letter market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. Show Less Read more